Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
- PMID: 19092168
- PMCID: PMC2606812
- DOI: 10.2337/dc08-9026
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
Erratum in
- Diabetes Care. 2009 Apr;32(4):754
Comment in
-
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.Diabetes Care. 2009 Jul;32(7):e90-1; author reply e92-3. doi: 10.2337/dc09-9030. Diabetes Care. 2009. PMID: 19564469 No abstract available.
Similar articles
-
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.Circulation. 2009 Jan 20;119(2):351-7. doi: 10.1161/CIRCULATIONAHA.108.191305. Epub 2008 Dec 17. Circulation. 2009. PMID: 19095622 No abstract available.
-
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008. J Am Coll Cardiol. 2009. PMID: 19147051 Review. No abstract available.
-
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.Diabetes Care. 2009 Jul;32(7):e90-1; author reply e92-3. doi: 10.2337/dc09-9030. Diabetes Care. 2009. PMID: 19564469 No abstract available.
-
[Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].Rev Med Suisse. 2008 Aug 6;4(166):1734. Rev Med Suisse. 2008. PMID: 18777740 French. No abstract available.
-
The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.Can J Diabetes. 2015 Dec;39 Suppl 5:S155-9. doi: 10.1016/j.jcjd.2015.09.009. Can J Diabetes. 2015. PMID: 26654859 Review.
Cited by
-
Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes.Diabetes Care. 2013 Oct;36(10):3297-304. doi: 10.2337/dc13-0149. Epub 2013 Jun 25. Diabetes Care. 2013. PMID: 23801723 Free PMC article.
-
6. Glycemic _targets: Standards of Care in Diabetes-2023.Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006. Diabetes Care. 2023. PMID: 36507646 Free PMC article. Review.
-
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.Diabetes Care. 2010 May;33(5):983-90. doi: 10.2337/dc09-1278. Diabetes Care. 2010. PMID: 20427682 Free PMC article. Clinical Trial.
-
The Use of Echocardiography and Advanced Cardiac Ultrasonography During Pregnancy.Curr Treat Options Cardiovasc Med. 2019 Nov 21;21(11):71. doi: 10.1007/s11936-019-0785-5. Curr Treat Options Cardiovasc Med. 2019. PMID: 31754837 Free PMC article. Review.
-
Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators.Int J Mol Sci. 2022 Jul 17;23(14):7886. doi: 10.3390/ijms23147886. Int J Mol Sci. 2022. PMID: 35887234 Free PMC article. Review.
References
-
- Reichard P, Bengt-Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309, 1993 - PubMed
-
- Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993 - PubMed
-
- Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103–117, 1995 - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865, 1998 - PubMed
-
- UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical